Copertina

Mortality risk following ischaemic and non‐ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000–2021

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Kajal Panchal, Claire A. Lawson, Sharmin Shabnam, Kamlesh Khunti, Francesco Zaccardi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Risk of Ischaemic and Non‐Ischaemic Heart Failure in People With Type 2 Diabetes: Observational Study in 1.6 Million People in England
di: Kajal Panchal, et al.
Pubblicazione: (2025)

The interplay between heart failure and chronic kidney disease
di: Anuradha Lala, et al.
Pubblicazione: (2025)

Body Mass Index and All‐Cause, Cancer, and Cardiovascular Mortality in Adults Aged 16–50 Years With and Without Type 2 Diabetes: An Analysis of Primary Care Records in England
di: Yijing Chen, et al.
Pubblicazione: (2026)

Differential associations of risk factors with severe and non‐severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin‐treated type 1 diabetes and type 2 diabetes
di: Ying He, et al.
Pubblicazione: (2024)

Taste perception genomics in gestational diabetes mellitus: A systematic review
di: Vishnu Shivam, et al.
Pubblicazione: (2024)

Five‐year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England
di: Atanu Bhattacharjee, et al.
Pubblicazione: (2025)

Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England
di: Sharmin Shabnam, et al.
Pubblicazione: (2026)

Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes
di: Setor K. Kunutsor, et al.
Pubblicazione: (2024)

Sodium‐glucose co‐transporter 2 inhibitors and obesity‐associated cancers in people with type 2 diabetes: A real‐world observational study
di: Testimony Ipaye, et al.
Pubblicazione: (2026)

Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019
di: Naomi Holman, et al.
Pubblicazione: (2024)

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
di: Naomi Holman, et al.
Pubblicazione: (2025)

Global, regional and national burden of ischaemic heart disease attributable to high body mass index and low physical activity from 1990 to 2021
di: Wenwen Lin, et al.
Pubblicazione: (2025)

Concerns regarding “ GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes”
di: Chien‐Hsiang Weng, et al.
Pubblicazione: (2025)

Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents
di: Setor K. Kunutsor, et al.
Pubblicazione: (2024)

GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population‐based study
di: Helen Tesfaye, et al.
Pubblicazione: (2025)

Front Cover
di: Anuradha Lala, et al.
Pubblicazione: (2025)

Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohorts
di: Safoora Gharibzadeh, et al.
Pubblicazione: (2025)

Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
di: Tamara Y. Milder, et al.
Pubblicazione: (2024)

Body mass index and remote ischaemic conditioning efficacy in acute ischaemic stroke patients: A post hoc analysis of the Remote Ischaemic Conditioning for Acute Moderate Ischaemic Stroke (RICAMIS) trial
di: Xiao‐Yu Sun, et al.
Pubblicazione: (2024)

Disparities in heart failure deaths among people with diabetes in the United States: 1999–2020
di: Benjamin Grobman, et al.
Pubblicazione: (2025)

Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
di: Jun‐Qiao An, et al.
Pubblicazione: (2025)

Sodium–glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real‐world, cohort data
di: Alex E. Henney, et al.
Pubblicazione: (2024)

Glucagon‐like peptide‐1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta‐analysis of observational studies
di: Ronald M. Goldenberg, et al.
Pubblicazione: (2025)

Interrelationship Between Baseline HbA1c , SGLT ‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
di: Samuel Seidu, et al.
Pubblicazione: (2026)

Long‐term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli‐durability 24‐month observational study
di: Rayaz A. Malik, et al.
Pubblicazione: (2025)

Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial
di: Daniel S. Nuyujukian, et al.
Pubblicazione: (2025)

Incidence of diabetes mellitus following hospitalisation for COVID ‐19 in the United Kingdom: A prospective observational study
di: Freya Tyrer, et al.
Pubblicazione: (2024)

Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial
di: Abderrahim Oulhaj, et al.
Pubblicazione: (2024)

Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
di: Testimony Ipaye, et al.
Pubblicazione: (2025)

Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007–2008 to 2023–2024
di: Muhammad Saleem Khan, et al.
Pubblicazione: (2026)

Using natriuretic peptides to screen for, identify and treat stage B heart failure in people with type 2 diabetes: An initial cost‐effectiveness analysis
di: William B. Horton, et al.
Pubblicazione: (2024)

Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study
di: Tzu‐Yang Chen, et al.
Pubblicazione: (2024)

Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes
di: Julian W. Sacre, et al.
Pubblicazione: (2026)

Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes
di: Takefumi Kishimori, et al.
Pubblicazione: (2026)

Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis
di: Khawaja M. Talha, et al.
Pubblicazione: (2024)

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
di: Mohmmad Alghamdi, et al.
Pubblicazione: (2025)

Psychometric evaluation of the Adelphi Adherence Questionnaire ( ADAQ ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care
di: Jan Stochl, et al.
Pubblicazione: (2025)

Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS
di: Fatema Said, et al.
Pubblicazione: (2024)

Clarity in Reporting Multiple Long‐Term Conditions in Research: The Need for Consistency and Consensus
di: Mark P. Funnell, et al.
Pubblicazione: (2026)

GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
di: Jirawan Vienghirun, et al.
Pubblicazione: (2026)